Ginseng Glucosyl Oleanolate from Ginsenoside Ro, Exhibited Anti-Liver Cancer Activities via MAPKs and Gut Microbiota In Vitro/Vivo

Ginseng is widely recognized for its diverse health benefits and serves as a functional food ingredient with global popularity. Ginsenosides with a broad range of pharmacological effects are the most crucial active ingredients in ginseng. This study aimed to derive ginseng glucosyl oleanolate (GGO) from ginsenoside Ro through enzymatic conversion and evaluate its impact on liver cancer in vitro and in vivo. GGO exhibited concentration-dependent HepG2 cell death and markedly inhibited cell proliferation via the MAPK signaling pathway. It also attenuated tumor growth in immunocompromised mice undergoing heterograft transplantation. Furthermore, GGO intervention caused a modulation of gut microbiota composition by specific bacterial populations, including Lactobacillus, Bacteroides, Clostridium, Enterococcus, etc., and ameliorated SCFA metabolism and colonic inflammation. These findings offer promising evidence for the potential use of GGO as a natural functional food ingredient in the prevention and treatment of cancer.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:72

Enthalten in:

Journal of agricultural and food chemistry - 72(2024), 14 vom: 10. Apr., Seite 7845-7860

Sprache:

Englisch

Beteiligte Personen:

Ai, Zhiyi [VerfasserIn]
Liu, Sitong [VerfasserIn]
Zhang, Junshun [VerfasserIn]
Hu, Yue [VerfasserIn]
Tang, Ping [VerfasserIn]
Cui, Linlin [VerfasserIn]
Wang, Xinzhu [VerfasserIn]
Zou, Hongyang [VerfasserIn]
Li, Xia [VerfasserIn]
Liu, Jingsheng [VerfasserIn]
Nan, Bo [VerfasserIn]
Wang, Yuhua [VerfasserIn]

Links:

Volltext

Themen:

34367-04-9
Cell proliferation
Food Ingredients
Ginseng glucosyl oleanolate
Ginsenoside Ro
Ginsenosides
HepG2 cells
Intestinal flora
Journal Article
SCFAs metabolism

Anmerkungen:

Date Completed 11.04.2024

Date Revised 11.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.jafc.3c08150

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369915542